Regulation of the Launch of Orphan Drugs on the Market of the Eurasian Economic Union as a Mechanism to Increase the Availability of Treatment for Rare Diseases (Review) | Foteeva | Drug development & registration

Drug development & registration
Razrabotka i registraciâ lekarstvennyh sredstv

ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)

eng | рус

Preview

Drug development & registration

Advanced search

Archives

Download this PDF file

For citations:

Foteeva A.V., Koneva N.A., Beloglazova O.S., Rostova N.B. Regulation of the Launch of Orphan Drugs on the Market of the Eurasian Economic Union as a Mechanism to Increase the Availability of Treatment for Rare Diseases (Review). Drug development & registration. 2023;12(2):198-205. (In Russ.) https://doi.org/10.33380/2305-2066-2023-12-2-198-205

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Shohin I.E.

Notifications

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

A. V. Foteeva
LLC "Parma Clinical"; Perm State Pharmaceutical Academy
Russian Federation

1b, Prichalnaya str., Perm, Perm Territory, 614042;
2, Polevaya str., Perm, 614990

N. A. Koneva
LLC "Parma Clinical"
Russian Federation

1b, Prichalnaya str., Perm, Perm Territory, 614042

O. S. Beloglazova
JSC "Medisorb"
Russian Federation

6/2, Galperina str., Perm, Perm Territory, 614042

N. B. Rostova
Perm State Pharmaceutical Academy; Perm State National Research University
Russian Federation

2, Polevaya str., Perm, 614990;
15, Bukireva str., Perm, Perm Territory, 614990